RT @CochraneKidney: New Cochrane Review Update: Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppress…
559 followers
1,129 followers
RT @CochraneKidney: New Cochrane Review Update: Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppress…
80,947 followers
Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients https://t.co/PBJt4oRTuG Systematic Review from @CochraneKidney includes 70 studies with 17,462 randomised participants.
203 followers
RT @CochraneKidney: New Cochrane Review Update: Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppress…